Antimicrobial Agents and Chemotherapy · 2016 · 39 citations · 24 references
MedicineMedicinal ChemistryPharmacologyDrug DiscoveryEnzymologyMolecular PharmacologyAntiparasitic AgentsAntiparasitic PharmacologyAntiparasitic TherapyCoenzyme ChemistryEnzyme InhibitionProtozoan Host-parasite InteractionsAntimalarial AgentsAntimalarial ChemotherapyAntimalarial Drug DevelopmentCoenzyme A BiosynthesisNovel Antiparasitic Compound ClassesPlasmodium FalciparumTreatment Of MalariaTriazole Chemistry
ABSTRACT The biosynthesis of coenzyme A (CoA) from pantothenate and the utilization of CoA in essential biochemical pathways represent promising antimalarial drug targets. Pantothenamides, amide derivatives of pantothenate, have potential as antimalarials, but a serum enzyme called pantetheinase degrades pantothenamides, rendering them inactive in vivo . In this study, we characterize a series of 19 compounds that mimic pantothenamides with a stable triazole group instead of the labile amide. Two of these pantothenamides are active against the intraerythrocytic stage parasite with 50% inhibitory concentrations (IC 50 s) of ∼50 nM, and three others have submicromolar IC 50 s. We show that the compounds target CoA biosynthesis and/or utilization. We investigated one of the compounds for its ability to interact with the Plasmodium falciparum pantothenate kinase, the first enzyme involved in the conversion of pantothenate to CoA, and show that the compound inhibits the phosphorylation of [ 14 C]pantothenate by the P. falciparum pantothenate kinase, but the inhibition does not correlate with antiplasmodial activity. Furthermore, the compounds are not toxic to human cells and, importantly, are not degraded by pantetheinase.
24
Human Malaria Parasites in Continuous Culture
William Trager, James B. Jensen · Science · 1976 · 8K citations
Kevin J. Saliba, Heather A. Horner, Kiaran Kirk · Journal of Biological Chemistry · 1998 · 235 citations · Full text